Unilever, the global owner of the Dermalogica brand has entered a joint venture with CAVI Brands, the shareholder of the existing South African Dermalogica business, The Dermal Institute of South Africa (Pty) Ltd (Dermalogica SA), to transform the local skincare industry. The newly formed entity is set to continue deliver cutting-edge product and solutions to meet the evolving needs of businesses and individuals in the skincare sector. The transaction was approved by the South African competition commission in September and with effective date of the sale of business, as of 1 October 2023.
“We believe that with this joint venture relationship concluded, we can only go from strength to strength in terms of the future development and growth of the South African Dermalogica business.” said Joanne Wilson, CEO of Dermalogica SA.
The new entity, Dermalogica SA, will continue to distribute Dermalogica products in South Africa based. The leadership structure in Dermalogica SA will remain the same as it is today. This joint venture merger combines the strengths and expertise of both companies, leveraging Unilever’s deep industry knowledge and CAVI Brands local knowledge and expertise of operating in the South African skincare industry. The result will be a continued offering that promises enhanced efficiency, scalability, and sustainability for Dermalogica’s valued customers.